These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 16085666

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Insulin response to oral glucose in healthy, lean young women and patients with polycystic ovary syndrome.
    Kulshreshtha B, Ganie MA, Praveen EP, Gupta N, Lal Khurana M, Seith A, Dwivedi SN, Kumar G, Ammini AC.
    Gynecol Endocrinol; 2008 Nov; 24(11):637-43. PubMed ID: 19031221
    [Abstract] [Full Text] [Related]

  • 23. Obesity, body composition and metabolic disturbances in polycystic ovary syndrome.
    Svendsen PF, Nilas L, Nørgaard K, Jensen JE, Madsbad S.
    Hum Reprod; 2008 Sep; 23(9):2113-21. PubMed ID: 18556679
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Indicators for metabolic disturbances in anovulatory women with polycystic ovary syndrome diagnosed according to the Rotterdam consensus criteria.
    Goverde AJ, van Koert AJ, Eijkemans MJ, Knauff EA, Westerveld HE, Fauser BC, Broekmans FJ.
    Hum Reprod; 2009 Mar; 24(3):710-7. PubMed ID: 19095675
    [Abstract] [Full Text] [Related]

  • 28. Prevalence of the metabolic syndrome in women with a previous diagnosis of polycystic ovary syndrome: long-term follow-up.
    Hudecova M, Holte J, Olovsson M, Larsson A, Berne C, Sundstrom-Poromaa I.
    Fertil Steril; 2011 Nov; 96(5):1271-4. PubMed ID: 21872228
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Severe endothelial dysfunction in young women with polycystic ovary syndrome is only partially explained by known cardiovascular risk factors.
    Sorensen MB, Franks S, Robertson C, Pennell DJ, Collins P.
    Clin Endocrinol (Oxf); 2006 Nov; 65(5):655-9. PubMed ID: 17054469
    [Abstract] [Full Text] [Related]

  • 37. Phenotypic characteristics according to insulin sensitivity in non-obese Korean women with polycystic ovary syndrome.
    Park HR, Choi Y, Lee HJ, Oh JY, Hong YS, Sung YA.
    Diabetes Res Clin Pract; 2007 Sep; 77 Suppl 1():S233-7. PubMed ID: 17606307
    [Abstract] [Full Text] [Related]

  • 38. [Study on the relationship between serum adiponectin and insulin resistance in women with polycystic ovary syndrome].
    Yang XF, Ren FR, Guo SP.
    Zhonghua Fu Chan Ke Za Zhi; 2006 Apr; 41(4):261-3. PubMed ID: 16759463
    [Abstract] [Full Text] [Related]

  • 39. Premature androgenic alopecia and insulin resistance. Male equivalent of polycystic ovary syndrome?
    Starka L, Duskova M, Cermakova I, Vrbiková J, Hill M.
    Endocr Regul; 2005 Dec; 39(4):127-31. PubMed ID: 16552990
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.